Selected research
Industry Research
Gene Synthesis Software Industry Research Report 2026
Market perspective
The global Gene Synthesis Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Gene Synthesis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Gene Synthesis Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Gene Synthesis Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Gene Synthesis Software include Eurofins Genomics, ATUM, Biotage, Bioneer Corporation, Eurogentec, GenScript, GENEWIZ, Integrated DNA Technologies and OriGene Technologies, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Gene Synthesis Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Gene Synthesis Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gene Synthesis Software Market by Company
Eurofins Genomics
ATUM
Biotage
Bioneer Corporation
Eurogentec
GenScript
GENEWIZ
Integrated DNA Technologies
OriGene Technologies
Thermo Fisher Scientific
Bio Basic
Twist Bioscience
BioCat GmbH
ProteoGenix
Charles River
Biosearch Technologies
Beijing SBS Genetech
Eton Bioscience
Gene Synthesis Software Segment by Type
Solid Phase Synthesis
Chip-based DNA Synthesis
PCR-based Enzyme Synthesis
Gene Synthesis Software Segment by Application
Academic and Research Institutes
Biotech and Pharmaceutical
Diagnostic Laboratories
Others
Gene Synthesis Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Synthesis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Synthesis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Synthesis Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gene Synthesis Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Solid Phase Synthesis
- Chip-based DNA Synthesis
- PCR-based Enzyme Synthesis
Applications
- Academic and Research Institutes
- Biotech and Pharmaceutical
- Diagnostic Laboratories
- Others
Companies covered
- Eurofins Genomics
- ATUM
- Biotage
- Bioneer Corporation
- Eurogentec
- GenScript
- GENEWIZ
- Integrated DNA Technologies
- OriGene Technologies
- Thermo Fisher Scientific
- Bio Basic
- Twist Bioscience
- BioCat GmbH
- ProteoGenix
- Charles River
- Biosearch Technologies
- Beijing SBS Genetech
- Eton Bioscience
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Gene Synthesis Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Solid Phase Synthesis
- 2.2.3 Chip-based DNA Synthesis
- 2.2.4 PCR-based Enzyme Synthesis
- 2.3 Gene Synthesis Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Academic and Research Institutes
- 2.3.3 Biotech and Pharmaceutical
- 2.3.4 Diagnostic Laboratories
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Gene Synthesis Software Breakdown Data by Type
- 3.1 Global Gene Synthesis Software Historic Market Size by Type (2021-2026)
- 3.2 Global Gene Synthesis Software Forecasted Market Size by Type (2027-2032)
4 Gene Synthesis Software Breakdown Data by Application
- 4.1 Global Gene Synthesis Software Historic Market Size by Application (2021-2026)
- 4.2 Global Gene Synthesis Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Gene Synthesis Software Market Perspective (2021-2032)
- 5.2 Global Gene Synthesis Software Growth Trends by Region
- 5.2.1 Global Gene Synthesis Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Gene Synthesis Software Historic Market Size by Region (2021-2026)
- 5.2.3 Gene Synthesis Software Forecasted Market Size by Region (2027-2032)
- 5.3 Gene Synthesis Software Market Dynamics
- 5.3.1 Gene Synthesis Software Industry Trends
- 5.3.2 Gene Synthesis Software Market Drivers
- 5.3.3 Gene Synthesis Software Market Challenges
- 5.3.4 Gene Synthesis Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Gene Synthesis Software Players by Revenue
- 6.1.1 Global Top Gene Synthesis Software Players by Revenue (2021-2026)
- 6.1.2 Global Gene Synthesis Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Gene Synthesis Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Gene Synthesis Software Head Office and Area Served
- 6.4 Global Gene Synthesis Software Players, Product Type & Application
- 6.5 Global Gene Synthesis Software Manufacturers Established Date
- 6.6 Global Gene Synthesis Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Gene Synthesis Software Market Size (2021-2032)
- 7.2 North America Gene Synthesis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Gene Synthesis Software Market Size by Country (2021-2026)
- 7.4 North America Gene Synthesis Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Gene Synthesis Software Market Size (2021-2032)
- 8.2 Europe Gene Synthesis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Gene Synthesis Software Market Size by Country (2021-2026)
- 8.4 Europe Gene Synthesis Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Synthesis Software Market Size (2021-2032)
- 9.2 Asia-Pacific Gene Synthesis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Gene Synthesis Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Gene Synthesis Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Gene Synthesis Software Market Size (2021-2032)
- 10.2 South America Gene Synthesis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Gene Synthesis Software Market Size by Country (2021-2026)
- 10.4 South America Gene Synthesis Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Synthesis Software Market Size (2021-2032)
- 11.2 Middle East & Africa Gene Synthesis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Gene Synthesis Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Gene Synthesis Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Eurofins Genomics
- 12.1.1 Eurofins Genomics Company Information
- 12.1.2 Eurofins Genomics Business Overview
- 12.1.3 Eurofins Genomics Revenue in Gene Synthesis Software Business (2021-2026)
- 12.1.4 Eurofins Genomics Gene Synthesis Software Product Portfolio
- 12.1.5 Eurofins Genomics Recent Developments
- 12.2 ATUM
- 12.2.1 ATUM Company Information
- 12.2.2 ATUM Business Overview
- 12.2.3 ATUM Revenue in Gene Synthesis Software Business (2021-2026)
- 12.2.4 ATUM Gene Synthesis Software Product Portfolio
- 12.2.5 ATUM Recent Developments
- 12.3 Biotage
- 12.3.1 Biotage Company Information
- 12.3.2 Biotage Business Overview
- 12.3.3 Biotage Revenue in Gene Synthesis Software Business (2021-2026)
- 12.3.4 Biotage Gene Synthesis Software Product Portfolio
- 12.3.5 Biotage Recent Developments
- 12.4 Bioneer Corporation
- 12.4.1 Bioneer Corporation Company Information
- 12.4.2 Bioneer Corporation Business Overview
- 12.4.3 Bioneer Corporation Revenue in Gene Synthesis Software Business (2021-2026)
- 12.4.4 Bioneer Corporation Gene Synthesis Software Product Portfolio
- 12.4.5 Bioneer Corporation Recent Developments
- 12.5 Eurogentec
- 12.5.1 Eurogentec Company Information
- 12.5.2 Eurogentec Business Overview
- 12.5.3 Eurogentec Revenue in Gene Synthesis Software Business (2021-2026)
- 12.5.4 Eurogentec Gene Synthesis Software Product Portfolio
- 12.5.5 Eurogentec Recent Developments
- 12.6 GenScript
- 12.6.1 GenScript Company Information
- 12.6.2 GenScript Business Overview
- 12.6.3 GenScript Revenue in Gene Synthesis Software Business (2021-2026)
- 12.6.4 GenScript Gene Synthesis Software Product Portfolio
- 12.6.5 GenScript Recent Developments
- 12.7 GENEWIZ
- 12.7.1 GENEWIZ Company Information
- 12.7.2 GENEWIZ Business Overview
- 12.7.3 GENEWIZ Revenue in Gene Synthesis Software Business (2021-2026)
- 12.7.4 GENEWIZ Gene Synthesis Software Product Portfolio
- 12.7.5 GENEWIZ Recent Developments
- 12.8 Integrated DNA Technologies
- 12.8.1 Integrated DNA Technologies Company Information
- 12.8.2 Integrated DNA Technologies Business Overview
- 12.8.3 Integrated DNA Technologies Revenue in Gene Synthesis Software Business (2021-2026)
- 12.8.4 Integrated DNA Technologies Gene Synthesis Software Product Portfolio
- 12.8.5 Integrated DNA Technologies Recent Developments
- 12.9 OriGene Technologies
- 12.9.1 OriGene Technologies Company Information
- 12.9.2 OriGene Technologies Business Overview
- 12.9.3 OriGene Technologies Revenue in Gene Synthesis Software Business (2021-2026)
- 12.9.4 OriGene Technologies Gene Synthesis Software Product Portfolio
- 12.9.5 OriGene Technologies Recent Developments
- 12.10 Thermo Fisher Scientific
- 12.10.1 Thermo Fisher Scientific Company Information
- 12.10.2 Thermo Fisher Scientific Business Overview
- 12.10.3 Thermo Fisher Scientific Revenue in Gene Synthesis Software Business (2021-2026)
- 12.10.4 Thermo Fisher Scientific Gene Synthesis Software Product Portfolio
- 12.10.5 Thermo Fisher Scientific Recent Developments
- 12.11 Bio Basic
- 12.11.1 Bio Basic Company Information
- 12.11.2 Bio Basic Business Overview
- 12.11.3 Bio Basic Revenue in Gene Synthesis Software Business (2021-2026)
- 12.11.4 Bio Basic Gene Synthesis Software Product Portfolio
- 12.11.5 Bio Basic Recent Developments
- 12.12 Twist Bioscience
- 12.12.1 Twist Bioscience Company Information
- 12.12.2 Twist Bioscience Business Overview
- 12.12.3 Twist Bioscience Revenue in Gene Synthesis Software Business (2021-2026)
- 12.12.4 Twist Bioscience Gene Synthesis Software Product Portfolio
- 12.12.5 Twist Bioscience Recent Developments
- 12.13 BioCat GmbH
- 12.13.1 BioCat GmbH Company Information
- 12.13.2 BioCat GmbH Business Overview
- 12.13.3 BioCat GmbH Revenue in Gene Synthesis Software Business (2021-2026)
- 12.13.4 BioCat GmbH Gene Synthesis Software Product Portfolio
- 12.13.5 BioCat GmbH Recent Developments
- 12.14 ProteoGenix
- 12.14.1 ProteoGenix Company Information
- 12.14.2 ProteoGenix Business Overview
- 12.14.3 ProteoGenix Revenue in Gene Synthesis Software Business (2021-2026)
- 12.14.4 ProteoGenix Gene Synthesis Software Product Portfolio
- 12.14.5 ProteoGenix Recent Developments
- 12.15 Charles River
- 12.15.1 Charles River Company Information
- 12.15.2 Charles River Business Overview
- 12.15.3 Charles River Revenue in Gene Synthesis Software Business (2021-2026)
- 12.15.4 Charles River Gene Synthesis Software Product Portfolio
- 12.15.5 Charles River Recent Developments
- 12.16 Biosearch Technologies
- 12.16.1 Biosearch Technologies Company Information
- 12.16.2 Biosearch Technologies Business Overview
- 12.16.3 Biosearch Technologies Revenue in Gene Synthesis Software Business (2021-2026)
- 12.16.4 Biosearch Technologies Gene Synthesis Software Product Portfolio
- 12.16.5 Biosearch Technologies Recent Developments
- 12.17 Beijing SBS Genetech
- 12.17.1 Beijing SBS Genetech Company Information
- 12.17.2 Beijing SBS Genetech Business Overview
- 12.17.3 Beijing SBS Genetech Revenue in Gene Synthesis Software Business (2021-2026)
- 12.17.4 Beijing SBS Genetech Gene Synthesis Software Product Portfolio
- 12.17.5 Beijing SBS Genetech Recent Developments
- 12.18 Eton Bioscience
- 12.18.1 Eton Bioscience Company Information
- 12.18.2 Eton Bioscience Business Overview
- 12.18.3 Eton Bioscience Revenue in Gene Synthesis Software Business (2021-2026)
- 12.18.4 Eton Bioscience Gene Synthesis Software Product Portfolio
- 12.18.5 Eton Bioscience Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst